Skip to main content

Integrating Geriatric Oncology in Public Health Planning

  • Living reference work entry
  • First Online:
Geriatric Oncology

Abstract

If more than 30% of cancers occur at present in France among elderly people, it is estimated that this proportion will reach 50–60% within the next two or three decades. To deal with and anticipate this challenge, successive national Cancer Control Plans have included specific actions on the organization of the treatment of elderly cancer patients. The organizational framework is based on an oncologist-geriatrician partnership at the head of oncogeriatrics coordination units. After a pilot phase conducted in 15 health care institutions, it has been deployed in 22 regions of mainland France and in one overseas territory. These units are mainly intended to ensure that each patient will receive a cancer treatment adapted to his overall health and not only related to his age. This organization evolves with both the evolution of the health landscape (in accordance with the modernization law of the health system of 26 January 2016), and the territorial reform that identifies13 regions in mainland France and five regions in overseas. It also has to take into account not only the therapeutic initial decision but also the patient’s pathway and his quality of life during and after the cancer treatment. His adaptation is essential to fully optimize the treatment of these elderly people suffering from cancer who will shortly represent the vast majority of people with cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Anhoury P, Pickhaert A-P, Ramsey B, Gochenauer G, Lifschitz S. The European oncologist approach to geriatric patients (Abstract). Crit Rev Oncol/Hematol. 2009;72(Suppl 1):S19.

    Article  Google Scholar 

  • Caillet P, Canoui-Poitrine F, Vouriot J, Berle M, Reinald N, Krypciak S, et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol. 2011;29(27):3636–42.

    Article  PubMed  Google Scholar 

  • Canouï-Poitrine F, Reinald N, Laurent M, Guery E, Caillet P, David JP, ELCAPA Study Group, et al. Geriatric assessment findings independently associated with clinical depression in 1902 older patients with cancer: the ELCAPA cohort study. Psychooncology. 2016;25:104–11.

    Article  PubMed  Google Scholar 

  • Chaïbi P, Magné N, Breton S, Chebib A, Watson S, Duron J-J, et al. Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients. Crit Rev Oncol Hematol. 2011;79(3):302–7.

    Article  PubMed  Google Scholar 

  • Chicoulaa B, Balardy L, Stillmunkes A, Mourey L, Oustric S, Rouge Bugat ME. French general practitioners’sense of isolation in the management of elderly cancer patients. Fam Pract. 2016;33(5):551–6.

    Article  PubMed  Google Scholar 

  • Corre R, Greiller L, Le Caër H, Audigier-Valette C, Baize N, Bérard H, et al. Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small-cell lung cancer: the phase III randomized ESOGIA-GFPC-GECP 08-02 study. J Clin Oncol. 2016;34(13):1476–83.

    Article  CAS  PubMed  Google Scholar 

  • Estimation de la prévalence (partielle et totale) du cancer en France métropolitaine chez les 15 ans et plus en 2008 – Étude à partir des registres des cancers du réseau Francim; Format : Brochure A4; Auteurs: Colonna M, Mitton N, Grosclaude P.; Date de publication : juillet 2014; ISBN : 978-2-37219-022-0; ISBN net : 978-2-37219-023-7; http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Estimation-de-la-prevalence-partielle-et-totale-du-cancer-en-France-metropolitaine-chez-les-15-ans-et-plus-en-2008 (2008). Accessed 25 Nov 2016.

  • Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007;25(14):1824–31.

    Article  PubMed  Google Scholar 

  • Farcet F, de Decker L, Pauly V, Rousseau F, Bergman H, Molines C, et al. Frailty markers and treatment decisions in patients seen in oncogeriatrics clinics : results from the ASRO pilot study. PLoS One. 2016;11(2):e0149732.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ferrat E, Paillaud E, Laurent M, Le Thuaut A, Caillet P, Tournigand C, ELCAPA Study Group, et al. Predictors of 1-year mortality in a prospective cohort of elderly patients with cancer. J Gerontol A Biol Sci Med Sci. 2015;70(9):1148–55.

    Article  PubMed  Google Scholar 

  • Ferrat E, Audureau E, Paillaud E, Liuu E, Tournigand C, Lagrange JL, ELCAPA Study Group, et al. Four distinct health profiles in older patients with cancer: latent class analysis of the prospective ELCAPA cohort. J Gerontol A Biol Sci Med Sci. 2016;71(12):1653–60. pii:glw052

    Article  PubMed  Google Scholar 

  • Hoppe S, Rainfray M, Fonck M, Hoppenreys L, Blanc J-F, Ceccaldi J, et al. Functional decline in older patients with cancer receiving first-line chemotherapy. J Clin Oncol. 2013;31(31):3877–82.

    Article  PubMed  Google Scholar 

  • Hurria A, Dale W, Mooney M, Rowland JH, Ballman KV, Cohen HJ, et al. Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations. J Clin Oncol. 2014;32(24):2587–94.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kelly CM, Power DG, Lichtman SM. Targeted therapy in older patients with solid tumors. J Clin Oncol. 2014;32(24):2635–46.

    Article  CAS  PubMed  Google Scholar 

  • Kurtz J-E, Heitz D, Enderlin P, Imbert F, Nehme H, Bergerat J-P, Dufour P. Geriatric oncology, general practitioners and specialists: current opinions and unmet needs. Crit Rev Oncol/Hematol. 2010;75(1):47–57.

    Article  Google Scholar 

  • Landre T, Uzzan B, Nicolas P, Aparicio T, Zelek L, Mary F, et al. Doublet chemotherapy vs. single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer. A meta-analysis. Int J Color Dis. 2015;30(10):1305–10.

    Article  Google Scholar 

  • Lange M, Heutte N, Rigal O, Noal S, Kurtz JE, Levy C, et al. Decline in cognitive function in older adults with early-stage breast cancer after adjuvant treatment. Oncologist. 2016; doi:10.1634/theoncologist.2016-0014.

  • Laurent M, des Guetz G, Batstuji-Garin S, Culine S, Caillet P, Aparicio T, et al. Chronological age and risk of chemotherapy non-feasibility : a real-life cohort study of 153 stage II or III colorectal cancer patients given adjuvant-modified FOLFOX6. Am J Clin Oncol. 2015; doi:10.1097/COC.0000000000000233.

  • Les Cancers en France. Type de document: Etude/Rapport; Auteurs: Natalie Vongmany, Philippe-Jean Bousquet; Editeur: Boulogne Billancourt [France] : INCa (Institut National du Cancer); Année de publication: 2016/04; Importance: 236p.; ISBN/ISSN/EAN : 978-2-37219-201-9; http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Les-cancers-en-France-Edition-2015 (2015). Accessed 25 Nov 2016.

  • Magnuson A, Dale W, Mohile S. Models of care in geriatric oncology. Curr Geriatr Resp. 2014;3(3):182–9.

    Article  CAS  Google Scholar 

  • Mandelblatt JS, Jacobsen PB, Ahles T. Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors. J Clin Oncol. 2014;32(24):2617–26.

    Article  PubMed  PubMed Central  Google Scholar 

  • McCleary NJ, Wigler D, Berry D, Sato K, Abrams T, Chan J, et al. Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy. Oncologist. 2013;18(1):64–72.

    Article  PubMed  PubMed Central  Google Scholar 

  • Mohile SG, Hurria A, Cohen HJ, Rowland JH, Leach CR, Arora NK, et al. Improving the quality of survivorship for older adults with cancer. Cancer. 2016;122(16):2459–68.

    Article  PubMed  Google Scholar 

  • Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. J Clin Oncol. 2015;33(13):1453–9.

    Article  PubMed  Google Scholar 

  • Oziel-Taieb S, Faure M, Gilabert M, Autret A, Turrini O, Moureau-Zabotto L, et al. Treatment of pancreatic adenocarcinoma in elderly patients over 75 years of age: a retrospective series of 129 patients. J Gastrointes Cancer. 2016;47(1):15–9.

    Article  CAS  Google Scholar 

  • Pamoukdjian F, Paillaud E, Zelek L, Laurent M, Lévy V, Landre T, et al. Measurement of gait speed in older adults to identify complications associated with frailty : a systematic review. J Geriatr Oncol. 2015;6(6):484–96.

    Article  PubMed  Google Scholar 

  • Petit-Monéger A, Rainfray M, Soubeyran P, Bellera CA, Mathoulin-Pélissier S. Detection of frailty in elderly cancer patients: improvement of the G8 screening test. J Geriatric Oncol. 2016;7(2):99–107.

    Article  Google Scholar 

  • Projection de l'incidence et de la mortalité par cancer en France métropolitaine en 2015 - Rapport technique; Format : Affichette; Date de publication : novembre 2015; Auteurs: Leone N, Voirin N, Roche L, Binder-Foucard F, Woronoff AS, Delafosse P, et al.; ISBN-NET : 979–10–289-0153-0, ISSN: 1956–6964; http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Projection-de-l-incidence-et-de-la-mortalite-par-cancer-en-France-metropolitaine-en-2015-Rapport-technique (2015). Accessed 25 Nov 2016.

  • Rivera C, Dahan M, Bernard A, Falcoz P-E, Thomas P. Surgical treatment of lung cancer in the octogenerians: results of a nationwide audit. Eur J Cardiothorac Surg. 2011;39(6):981–6.

    Article  PubMed  Google Scholar 

  • Rivoirard R, Chargari C, Kullab S, Trone J-C, Langrand-Escure J, Moriceau G, et al. Chemotherapy regimen in nonagenarian cancer patients: a bi-institutional experience. Chemotherapy. 2016;61(2):65–71.

    Article  PubMed  Google Scholar 

  • Sabatier R, Calderon B Jr, Lambaudie E, Chereau E, Provansal M, Cappiello MA, et al. Prognostic factors for ovarian epithelial cancer in the elderly: a case-control study. Int J Gynecol Cancer. 2015;25(5):815–22.

    Article  PubMed  Google Scholar 

  • Scher KS, Hurria A. Under-representation of older adults in cancer registration trials: known problem, little progress. J Clin Oncol. 2012;30(17):2036–8.

    Article  PubMed  Google Scholar 

  • Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy. The process of deprescribing. JAMA Intern Med. 2015;175(5):827–34.

    Article  PubMed  Google Scholar 

  • Soubeyran P, Bellera C, Goyard J, Heitz D, Cure H, Rousselot H, et al. Screening for vulnerability in older cancer patients: the ONCODAGE prospective multicenter cohort study. PLoS One. 2014;9(12):e 115060.

    Article  Google Scholar 

  • Wildiers H, Mauer M, Pallis A, Hurria A, Mohile SG, Luciani A, et al. End points and trial design in geriatric oncology research: a joint European organization for research and treatment of cancer - alliance for clinical trials in oncology – international society of geriatric oncology position article. J Clin Oncol. 2013;31(29):3711–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeanne-Marie Bréchot .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Bréchot, JM., Bousquet, PJ., Ferrari, C., Viguier, J., Ifrah, N. (2017). Integrating Geriatric Oncology in Public Health Planning. In: Extermann, M. (eds) Geriatric Oncology . Springer, Cham. https://doi.org/10.1007/978-3-319-44870-1_91-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44870-1_91-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-44870-1

  • Online ISBN: 978-3-319-44870-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics